{"title":"Association of Brain Derived Neurotrophic Factor with Iron as well as Vitamin D, Folate and Cobalamin in Pediatric Metabolic Syndrome","authors":"Mustafa M. Donma, Orkide Donma","volume":158,"journal":"International Journal of Medical and Health Sciences","pagesStart":57,"pagesEnd":61,"ISSN":"1307-6892","URL":"https:\/\/publications.waset.org\/pdf\/10011060","abstract":"
The impact of metabolic syndrome (MetS) on cognition and functions of the brain is being investigated. Iron deficiency and deficiencies of B9 (folate) as well as B12 (cobalamin) vitamins are best-known nutritional anemias. They are associated with cognitive disorders and learning difficulties. The antidepressant effects of vitamin D are known and the deficiency state affects mental functions negatively. The aim of this study is to investigate possible correlations of MetS with serum brain-derived neurotrophic factor (BDNF), iron, folate, cobalamin and vitamin D in pediatric patients. 30 children, whose age- and sex-dependent body mass index (BMI) percentiles vary between 85 and 15, 60 morbid obese children with above 99th<\/sup> percentiles constituted the study population. Anthropometric measurements were taken. BMI values were calculated. Age- and sex-dependent BMI percentile values were obtained using the appropriate tables prepared by the World Health Organization (WHO). Obesity classification was performed according to WHO criteria. Those with MetS were evaluated according to MetS criteria. Serum BDNF was determined by enzyme-linked immunosorbent assay. Serum folate was analyzed by an immunoassay analyzer. Serum cobalamin concentrations were measured using electrochemiluminescence immunoassay. Vitamin D status was determined by the measurement of 25-hydroxycholecalciferol [25-hydroxy vitamin D3, 25(OH)D] using high performance liquid chromatography. Statistical evaluations were performed using SPSS for Windows, version 16. The p values less than 0.05 were accepted as statistically significant. Although statistically insignificant, lower folate and cobalamin values were found in MO children compared to those observed for children with normal BMI. For iron and BDNF values, no alterations were detected among the groups. Significantly decreased vitamin D concentrations were noted in MO children with MetS in comparison with those in children with normal BMI (p ≤ 0.05). The positive correlation observed between iron and BDNF in normal-BMI group was not found in two MO groups. In THE MetS group, the partial correlation among iron, BDNF, folate, cobalamin, vitamin D controlling for waist circumference and BMI was r = -0.501; p ≤ 0.05. None was calculated in MO and normal BMI groups. In conclusion, vitamin D should also be considered during the assessment of pediatric MetS. Waist circumference and BMI should collectively be evaluated during the evaluation of MetS in children. Within this context, BDNF appears to be a key biochemical parameter during the examination of obesity degree in terms of mental functions, cognition and learning capacity. The association observed between iron and BDNF in children with normal BMI was not detected in MO groups possibly due to development of inflammation and other obesity-related pathologies. It was suggested that this finding may contribute to mental function impairments commonly observed among obese children.<\/p>\r\n","references":"[1]\tA. A. Nikonorov, M. G. Skalnaya, A. A. Tinkov, and A. V. Skalny, \u201cMutual interaction between iron homeostasis and obesity pathogenesis,\u201d J Tr El Med Biol, vol. 30, pp. 207-214, Apr. 2015.\r\n[2]\tC. A. Hutchinson, \u201cA review of iron studies in overweight and obese children and adolescents: a double burden in the young?\u201d Eur. J. Nutr., vol. 55, pp. 2179\u20132197, 2016\r\n[3]\tM. Citelli, T. Faria, V. Silva, M. Martins, R. Silva, A. Luna et.al., \u201cObesity promotes alterations in iron recycling,\u201d Nutrients, vol. 7, pp. 335-348, 2015.\r\n[4]\tS. A. Ritchie, and J. M. C. Connell, \u201cThe link between abdominal obesity, metabolic syndrome and cardiovascular disease,\u201d Nutr. Metab. Cardiovasc. Dis., vol. 17, pp. 319-326, 2007.\r\n[5]\tA. Del Parigi, F. Panza, C. Capurso, and V. Solfrizzi, \u201cNutritional factors, cognitive decline and dementia,\u201d Brain. Res. Bull., vol 69, no. 1, pp.1-19, Mar. 2006.\r\n[6]\tR. Green, and A. D. Mitra, \u201cMegaloblastic anemias: Nutritional and other causes,\u201d Med. Clin. North Am., vol 101, no. 2, pp. 297-317, Mar. 2017.\r\n[7]\tM. M. Donma and O. Donma, \u201cCobalamin, folate and metabolic syndrome parameters in pediatric morbid obesity and metabolic syndrome,\u201d Int J Med Health Sci, vol.12, no.5, pp.249-252, May 2018.\r\n[8]\tM. S. Boulkrane, J. Fedotova , V. Kolodyaznaya, V. Micale, F. Drago, A. J. M. V. den Tol et. al., \u201cVitamin D and depression in women: a mini-review,\u201d Curr. Neuropharmacol., Nov. 2019, (E-pub ahead of print).\r\n[9]\tJ. Zugic-Soares, R. Pettersen, J. Saltyte Benth, A. B. Knapskog, G. Selbaek, and N. Bogdanovic, \u201cHigher vitamin D levels are associated with better attentional functions: Data from the NorCog Register,\u201d J. Nutr. Health Aging, vol. 23, no.8, pp. 725-731, 2019.\r\n[10]\tO. Donma and M. M. Donma, \u201cEvaluation of vitamin D levels in obese and morbid obese children,\u201d Int J Med Health Sci, vol.12, no.5, pp.245-248, May 2018.\r\n[11]\tR. A. H. Adan, E. M. van der Beek, J. K. Buitelaar, J. F. Cryan, J. Hebebrand, S. Higgs et. al., \u201cNutritional psychiatry: Towards improving mental health by what you eat,\u201d Eur. Neuropsychopharmacol., Nov. 2019, (E-pub ahead of print\r\n[12]\tS. Araki, Y. Yamamoto, K. Dobashi, K. Asayama, and K. Kusuhara, \u201cDecreased plasma levels of brain-derived neurotrophic factor and its relationship with obesity and birth weight in obese Japanese children,\u201d Obes. Res. Clin. Pract., vol.8, no.1, pp. e63-e69, Jan.-Feb. 2014.\r\n[13]\tJ. D. Mart\u00ednez-Ezquerro, M. E. Rend\u00f3n-Mac\u00edas, G. Zamora-Mendoza, J. Serrano-Meneses, B. Rosales-Rodriguez, D. Escalante-Bautista et al., \u201cAssociation between the brain-derived neurotrophic factor val66met polymorphism and overweight\/obesity in pediatric population,\u201d Arch. Med. Res., vol. 48, no. 7, pp. 599-608, Oct. 2017.\r\n[14]\tL. Lughetti, E. Casarosa, B. Predieri, V. Patianna, and S. Luisi, \u201cPlasma brain-derived neurotrophic factor concentrations in children and adolescents,\u201d Neuropeptides, vol. 45, no. 3, pp.205-211, Jun. 2011.\r\n[15]\tA. H. El-Gharbawy, D. C. Adler-Wailes, M. C. Mirch, K. R. Theim, L. Ranzenhofer, M. Tanofsky-Kraff et al., \u201cSerum brain-derived neurotrophic factor concentrations in lean and overweight children and adolescents,\u201d J. Clin. Endocrinol. Metab., vol. 91, no. 9, pp. 3548-3552, Sep. 2006.\r\n[16]\tC. C. Lin, C. T. Lee, Y. T. Lo, T. L. Huang, \u201cBrain-derived neurotrophic factor protein and mRNA levels in patients with bipolar mania-A preliminary study,\u201d Biomed. J., vol. 39, no. 4, pp. 272-276, Aug. 2016. \r\n[17]\tS. Mehrpouya, A. Nahavandi, F. Khojasteh, M. Soleimani, M. Ahmadi, and M. Barati, \u201cIron administration prevents BDNF decrease and depressive-like behavior following chronic stress,\u201d Brain Res., vol. 1596, pp. 79-87, Jan. 2015.\r\n[18]\tJ. A. Estrada, I. Contreras, F. B. Pliego-Rivero, and G. A. Otero, \u201cMolecular mechanisms of cognitive impairment in iron deficiency: alterations in brain-derived neurotrophic factor and insulin-like growth factor expression and function in the central nervous system,\u201d Nutr. Neurosci., vol. 17, no. 5, pp. 193-206, 2014.\r\n[19]\tS. Motamedi, I. Karimi, and F. Jafari, \u201cThe interrelationship of metabolic syndrome and neurodegenerative diseases with focus on brain-derived neurotrophic factor (BDNF): Kill two birds with one stone,\u201d Metab. Brain Dis., vol 32, no. 3, pp. 651-665, Jun. 2017.\r\n[20]\tWorld Health Organization (WHO). The WHO Child Growth Standards. Available at: http:\/\/www.who.int\/childgrowth\/en\/ Accessed on June 10, 2016.\r\n[21]\tP. Zimmet, K. G. Alberti, F. Kaufman, N. Tajima, M. Silink, S. Arslanian, G. Wong, P. Bennett, J. Shaw, S. Caprio, and IDF consensus group, \u201cThe metabolic syndrome in children and adolescents- an IDF consensus report\u201d, Pediatr. Diabetes, vol. 8, no. 5, pp. 299 - 306, Oct. 2007.\r\n[22]\tF. P. N. Arcanjo, C. P. C Arcanjo, and P. R. Santos, \u201cSchool children with learning difficulties have low iron status and high anemia prevalence,\u201d J. Nutr. Metab., vol. 2016, Article ID. 73571, 2016.\r\n[23]\tR. Haussman, C. Sauer, S. Neumann, A. Zweiniger, J. Lange, and M. Donix, \u201cFolic acid and vitamin B12 determination in the assessment of cognitive disorders,\u201d Nervenarzt, vol.90, no. 11, pp. 1162-1169, Nov. 2019.\r\n[24]\tJ. I. B. Botella-Carretero, F. Alvarez-Blasco, JJ Villafruela, J. A. Balsa, C. Vazquez, and H. F. Escobar-Morreale, \u201cVitamin D deficiency is associated with the metabolic syndrome in morbid obesity,\u201d Clin. Nutr., vol.26, no.5, pp.573-580, Nov. 2007.\r\n[25]\tJ. M. Ordonez-Mena, B. Schottker, V. Fedirko, M. Jenab, A. Olsen, J. Halkjaer, et al., \u201cPre-diagnostic vitamin D concentrations and cancer risks in older individuals: an analysis of cohorts participating in the CHANCES consortium,\u201d Eur. J. Epidemiol., vol. 31, no.3, pp. 311-323, Mar. 2016\r\n[26]\tM. Matejcic, J. de Batlle, C. Ricci, C. Biessy, F. Perrier, I, Huybrechts et al, \u201cBiomarkers of folate and vitamin B12 and breast cancer risk: report from the EPIC cohort,\u201d Int. J. Cancer, vol. 140, no. 6, pp. 1246-1259, Mar. 2017.\r\n[27]\tB. Krusinska, L. Wadolowska, M. Biernacki, M. A. Slowinska, and M. Drozdowski, \u201cSerum \u201cvitamin-mineral\u201d profiles. Associations with postmenaupausal breast cancer risk including dietary patterns and supplementation. A case-control study,\u201d Nutrients, vol.11, pp.2244, 2019.","publisher":"World Academy of Science, Engineering and Technology","index":"Open Science Index 158, 2020"}